UBS Group Issues Positive Forecast for BrightSpring Health Services (NASDAQ:BTSG) Stock Price

BrightSpring Health Services (NASDAQ:BTSG) had its price target lifted by UBS Group from $31.00 to $35.00 in a report published on Monday,Benzinga reports. UBS Group currently has a buy rating on the stock.

A number of other equities research analysts also recently weighed in on BTSG. Deutsche Bank Aktiengesellschaft set a $30.00 target price on BrightSpring Health Services and gave the stock a “buy” rating in a research report on Monday, September 8th. TD Cowen began coverage on BrightSpring Health Services in a research report on Monday, June 23rd. They set a “buy” rating and a $37.00 target price on the stock. Wells Fargo & Company lifted their target price on BrightSpring Health Services from $27.00 to $33.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Weiss Ratings reissued a “hold (c-)” rating on shares of BrightSpring Health Services in a research report on Wednesday, October 8th. Finally, Bank of America lifted their target price on BrightSpring Health Services from $27.50 to $31.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. Nine investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $30.50.

BrightSpring Health Services Trading Up 3.9%

Shares of NASDAQ:BTSG opened at $29.48 on Monday. The company has a market cap of $5.22 billion, a P/E ratio of 95.10, a P/E/G ratio of 0.47 and a beta of 2.40. The stock’s 50-day moving average is $25.49 and its 200-day moving average is $22.39. BrightSpring Health Services has a 52-week low of $14.73 and a 52-week high of $30.35. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.34 and a current ratio of 1.76.

BrightSpring Health Services (NASDAQ:BTSG) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.03. BrightSpring Health Services had a return on equity of 9.29% and a net margin of 0.55%.The company had revenue of $3.15 billion for the quarter, compared to the consensus estimate of $2.99 billion. During the same period last year, the business posted $0.10 earnings per share. The firm’s revenue was up 15.3% compared to the same quarter last year. BrightSpring Health Services has set its FY 2025 guidance at EPS. Equities research analysts predict that BrightSpring Health Services will post 0.59 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC bought a new position in BrightSpring Health Services during the second quarter worth about $43,000. Sandia Investment Management LP bought a new position in BrightSpring Health Services during the second quarter worth about $118,000. Penserra Capital Management LLC bought a new position in shares of BrightSpring Health Services in the second quarter valued at approximately $139,000. IFP Advisors Inc raised its stake in shares of BrightSpring Health Services by 273,666.7% in the first quarter. IFP Advisors Inc now owns 8,213 shares of the company’s stock valued at $149,000 after acquiring an additional 8,210 shares during the last quarter. Finally, Highland Capital Management LLC bought a new position in shares of BrightSpring Health Services in the first quarter valued at approximately $181,000.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.